Carmignac Gestion Surmodics Inc Transaction History
Carmignac Gestion
- $6.18 Billion
- Q2 2025
A detailed history of Carmignac Gestion transactions in Surmodics Inc stock. As of the latest transaction made, Carmignac Gestion holds 27,622 shares of SRDX stock, worth $1.05 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,622
Previous 61,074
54.77%
Holding current value
$1.05 Million
Previous $1.86 Million
56.01%
% of portfolio
0.01%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding SRDX
# of Institutions
144Shares Held
12.5MCall Options Held
103KPut Options Held
212K-
Black Rock Inc. New York, NY1.17MShares$44.4 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY850KShares$32.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA810KShares$30.7 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT789KShares$29.9 Million1.82% of portfolio
-
Morgan Stanley New York, NY656KShares$24.9 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $531M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...